Amniotics AB (OSTO:AMNI) Institutional Ownership : 0.01% (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Amniotics AB's institutional ownership is 0.01%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Amniotics AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Amniotics AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Amniotics AB Institutional Ownership Historical Data

The historical data trend for Amniotics AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Institutional Ownership Chart

Amniotics AB Historical Data

The historical data trend for Amniotics AB can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01

Amniotics AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Amniotics AB (OSTO:AMNI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

66J:Germany

Address

Scheelevagen 2, Lund, SWE, 223 63

Website

https://www.amniotics.com

Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.